Aperio Group’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-12,635
| Closed | -$76K | – | 2446 |
|
|
2019
Q4 | $76K | Buy |
12,635
+1,363
| +12% | +$8.2K | ﹤0.01% | 2284 |
|
|
2019
Q3 | $41K | Buy |
11,272
+6,080
| +117% | +$22.1K | ﹤0.01% | 2287 |
|
|
2019
Q2 | $14K | Buy |
+5,192
| New | +$14K | ﹤0.01% | 2745 |
|
|
2016
Q1 | – | Sell |
-11,644
| Closed | -$126K | – | 2085 |
|
|
2015
Q4 | $126K | Buy |
11,644
+461
| +4% | +$4.99K | ﹤0.01% | 1901 |
|
|
2015
Q3 | $77K | Buy |
11,183
+523
| +5% | +$3.6K | ﹤0.01% | 1883 |
|
|
2015
Q2 | $94K | Sell |
10,660
-10,878
| -51% | -$95.9K | ﹤0.01% | 1952 |
|
|
2015
Q1 | $212K | Buy |
21,538
+5,293
| +33% | +$52.1K | ﹤0.01% | 1800 |
|
|
2014
Q4 | $199K | Buy |
16,245
+5,863
| +56% | +$71.8K | ﹤0.01% | 1752 |
|
|
2014
Q3 | $104K | Buy |
+10,382
| New | +$104K | ﹤0.01% | 1687 |
|